-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UYwSgQzl8X9wu1se/Evmw2omty7n/0lRTkaibK9BRsLCtI7CLmZCjoxu0sLw77QU wVnK5Zg7qwydKZ1KdLHQEg== 0001367982-07-000386.txt : 20070906 0001367982-07-000386.hdr.sgml : 20070906 20070906164811 ACCESSION NUMBER: 0001367982-07-000386 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070904 FILED AS OF DATE: 20070906 DATE AS OF CHANGE: 20070906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYLIN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000881464 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330266089 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195522200 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROWLAND LLOYD A CENTRAL INDEX KEY: 0001236395 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19700 FILM NUMBER: 071103124 BUSINESS ADDRESS: BUSINESS PHONE: 8585522200 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2007-09-04 0 0000881464 AMYLIN PHARMACEUTICALS INC AMLN 0001236395 ROWLAND LLOYD A 9360 TOWNE CENTRE DR SAN DIEGO CA 92121 0 1 0 0 VP, Gov/Compliance, Secretary Common Stock 2007-09-04 4 M 0 1887 18.85 A 25372 D Common Stock 2007-09-04 4 S 0 1887 48.9943 D 23485 D Common Stock 2007-09-04 4 M 0 113 22.6 A 23598 D Common Stock 2007-09-04 4 S 0 113 48.9943 D 23485 D Incentive Stock Option (right to buy) 18.85 2007-09-04 4 M 0 1887 0 D 2013-05-12 Common Stock 1887 0 D Incentive Stock Option (right to buy) 22.6 2007-09-04 4 M 0 113 0 D 2014-05-04 Common Stock 113 4482 D This sale was affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. 10,000 options vested on 05/12/04, and monthly after that, until all the 40,000 options were completely vested on 05/12/07. 8,750 options vested on 05/04/05, and monthly after that, until all the 35,000 options will be completely vested on 05/4/08. By: /s/Lloyd A. Rowland, Attorney-in-Fact For: Lloyd A. Rowland 2007-09-06 -----END PRIVACY-ENHANCED MESSAGE-----